Select SPDR Healthcare ETF - XLV
Stocks to Watch: Stocks in focus for Monday (at MarketWatch)
Among the companies whose shares are expected to see active trading Monday are Apple, Citigroup and Exxon Mobil
Categories: Select SPDR Healthcare ETF - XLV
[$$] FDA Adds Warning to Plavix (at The Wall Street Journal Online)
Categories: Select SPDR Healthcare ETF - XLV
UPDATE - US FDA panel backs Medtronic implant for epilepsy (at Reuters)
Categories: Select SPDR Healthcare ETF - XLV
FDA warning: some patients cannot process Plavix (AP)
The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.
Categories: Select SPDR Healthcare ETF - XLV
FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy (Business Wire)
MINNEAPOLIS----The U.S. Food and Drug Administration Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain Stimulation Therapy for Epilepsy from Medtronic, Inc. as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy.
Categories: Select SPDR Healthcare ETF - XLV
[$$] FDA Panel Backs Device For Epilepsy (at The Wall Street Journal Online)
Categories: Select SPDR Healthcare ETF - XLV
FDA panel backs Medtronic epilepsy device: AP (at MarketWatch)
Categories: Select SPDR Healthcare ETF - XLV
FDA panel backs Medtronic brain stimulator (AP)
Federal health advisers say a brain stimulating device from Medtronic can be approved for epilespy, provided the company conducts follow-up safety studies.
Categories: Select SPDR Healthcare ETF - XLV
A Black-Box Warning for Plavix. Confusion May Follow (at The Wall Street Journal Online)
Categories: Select SPDR Healthcare ETF - XLV
FDA finds shortcomings in Amylin's West Chester plant (at bizjournals.com)
Categories: Select SPDR Healthcare ETF - XLV
WEEKAHEAD-The view from Reuters editors in the Americas (at Reuters)
Categories: Select SPDR Healthcare ETF - XLV
Summary Box: FDA puts black box warning on Plavix (AP)
PLAVIX PROBLEM: The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.
Categories: Select SPDR Healthcare ETF - XLV
UPDATE - US FDA releases Amylin inspection report (at Reuters)
Categories: Select SPDR Healthcare ETF - XLV
Medtronic offers senior notes totaling $3 billion (AP)
Medical device maker Medtronic Inc. has announced an offering of senior notes totaling $3 billion for working capital and general corporate purposes.
Categories: Select SPDR Healthcare ETF - XLV
[$$] Big Drug Firms Most Exposed to Generics (at Barrons.com)
Big Drug Firms Most Exposed to Generics Credit Suisse says AstraZeneca, Lilly and Bristol-Myers are the most at risk.
Categories: Select SPDR Healthcare ETF - XLV
Medtronic Starts International Study of CoreValve® Transcatheter Aortic Valve System (Business Wire)
MINNEAPOLIS----Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. , today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement.
Categories: Select SPDR Healthcare ETF - XLV
Recent comments
8 hours 24 min ago
13 weeks 4 days ago
18 weeks 4 days ago
22 weeks 2 days ago
28 weeks 1 day ago
32 weeks 3 days ago
42 weeks 3 days ago
43 weeks 3 days ago
51 weeks 3 days ago
1 year 5 weeks ago